Skip to main content

Table 6 Results of subgroup analysis

From: Correlation of perfluoroalkyl and polyfluoroalkyl substance levels during pregnancy with gestational diabetes mellitus: a systematic review and meta-analysis

PFAS

Study site

Publication year

Sampling period

Methods of chemical analysis

 

China

Western countries

before 2020

2020 and later

Preconception

Early pregnancy

Late pregnancy

HPLC

UPLC

PFOA

         

Combined SMD (95% CI)

2.405 (1.516, 3.294)

0.759 (-0.602, 2.121)

0.535 (-0.166, 1.236)

3.829 (2.617, 5.041)

2.493 (2.045, 2.94)

0.102 (-0.039, 0.243)

16.921 (-16.594, 50.435)

0.045 (-0.06,0.149)

0.045 (-0.135,0.225)

Combined OR (95% CI)

1.954 (1.538, 2.483)

0.952 (0.690, 1.314)

0.862 (0.6, 1.237)

1.889 (1.503, 2.37)

/

1.804 (1.436, 2.265)

1.071 (0.709, 1.617)

/

/

PFOS

         

Combined SMD (95% CI)

0.529 (-0.136, 1.193)

0.005 (-0.188, 0.197)

-0.035 (-0.259, 0.19)

0.775 (-0.094, 1.644)

0.142 (-0.251, 0.534)

0.026 (-0.079, 0.132)

1.836 (-2.115, 5.787)

0.004 (-0.107,0.115)

0.015 (-0.089,0.118)

Combined OR (95% CI)

1.253 (0.958, 1.641)

0.976 (0.715, 1.330)

0.887 (0.629, 1.249)

1.281 (0.995, 1.649)

/

1.207 (0.944, 1.543)

1.156 (0.747, 1.789)

/

/

PFBS

         

Combined SMD (95% CI)

0.282 (0.008, 0.557)

/

0 (-0.302, 0.302)

0.347 (0.027, 0.667)

/

0.336 (-0.072, 0.744)

/

/

/